NCT02517619View on ClinicalTrials.gov

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

January 16, 2016

Primary Completion Date

April 20, 2018

Study Completion Date

May 29, 2018

Conditions
Anterior Uveitis
Interventions
DRUG

Dexamethasone Phosphate Ophthalmic Solution

40 mg/mL

DRUG

Prednisolone Acetate Ophthalmic (1%)

Prednisolone Acetate (1%)

Trial Locations (1)

23502

Virginia Eye Consultants, Norfolk

Sponsors
All Listed Sponsors
lead

Eyegate Pharmaceuticals, Inc.

INDUSTRY